Found: 7
Select item for more details and to access through your institution.
Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 2, p. 178, doi. 10.1002/ajh.25680
- By:
- Publication type:
- Article
Lymphom der Prostata – Diagnose auf den „zweiten Stich“.
- Published in:
- Medizinische Klinik (Urban & Vogel), 2008, v. 103, n. 4, p. 245, doi. 10.1007/s00063-008-1034-y
- By:
- Publication type:
- Article
Leukaemia cell lines are robust in vitro models – response to MacLeod & Drexler.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Gene expression profiling reveals consistent differences between clinical samples of human leukaemias and their model cell lines.
- Published in:
- British Journal of Haematology, 2006, v. 135, n. 4, p. 520, doi. 10.1111/j.1365-2141.2006.06342.x
- By:
- Publication type:
- Article
Disparate expression of the PTEN gene: a novel finding in B-cell chronic lymphocytic leukaemia (B-CLL).
- Published in:
- British Journal of Haematology, 2003, v. 121, n. 1, p. 97, doi. 10.1046/j.1365-2141.2003.04227.x
- By:
- Publication type:
- Article
Cusatuzumab for treatment of CD70‐positive relapsed or refractory cutaneous T‐cell lymphoma.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 5, p. 1004, doi. 10.1002/cncr.34005
- By:
- Publication type:
- Article
Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans.
- Published in:
- 2018
- By:
- Publication type:
- journal article